Pluri (PLUR) Receivables (2011 - 2024)
Pluri (PLUR) posted quarterly Receivables of $44000.0 for Q2 2024, down 70.27% year-over-year from $148000.0 in Q3 2023, and down 70.27% quarter-over-quarter from $148000.0 in Q2 2023.
Pluri (PLUR) Receivables (2011 - 2024) Analysis & Trends
Pluri (PLUR) has reported Receivables for 14 consecutive years, with $44000.0 the latest figure, recorded in Q2 2024.
- In Q2 2024, Receivables fell 70.27% year-over-year to $44000.0; the TTM figure through Jun 2024 stood at $44000.0 (down 70.27% YoY), while the FY2024 annual figure was $44000.0, down 70.27% from the prior year.
- Receivables slipped to $44000.0 in Q2 2024 per PLUR's latest filing, from $148000.0 in the prior quarter.
- Across five years, Receivables topped out at $1.2 million in Q2 2020 and bottomed at $19000.0 in Q2 2021.
- Historically, Receivables has averaged $155090.9 across 5 years, with a median of $52000.0 in 2021.
- Annual changes were most pronounced in 2021 — Receivables sank 98.36% — and 2023, when it jumped 492.0%.
- Pluri's Receivables stood at $1.2 million in 2020, then slumped by 95.51% to $52000.0 in 2021, then changed by 0.0% to $52000.0 in 2022, then jumped by 184.62% to $148000.0 in 2023, then slumped by 70.27% to $44000.0 in 2024.
- Business Quant data shows PLUR's Receivables at $44000.0 in Q2 2024, $148000.0 in Q2 2023, and $52000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Pluri | 15.74 Mn | 3.26 Mn | 86,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 44,000.00 |
| Jun 30, 2023 | 148,000.00 |
| Mar 31, 2023 | 52,000.00 |
| Dec 31, 2022 | 52,000.00 |
| Sep 30, 2022 | 52,000.00 |
| Jun 30, 2022 | 25,000.00 |
| Mar 31, 2022 | 52,000.00 |
| Dec 31, 2021 | 52,000.00 |
| Sep 30, 2021 | 52,000.00 |
| Jun 30, 2021 | 19,000.00 |
| Jun 30, 2020 | 1.16 Mn |
| Mar 31, 2019 | 488,000.00 |
| Dec 31, 2018 | 127,000.00 |
| Sep 30, 2018 | 16,000.00 |
| Jun 30, 2018 | -480,000.00 |
| Mar 31, 2018 | 1.02 Mn |
| Dec 31, 2017 | 319,000.00 |
| Sep 30, 2017 | -986,000.00 |
| Jun 30, 2017 | 1.75 Mn |
| Mar 31, 2017 | 349,000.00 |